C
Edwards Lifesciences Corporation EW
$81.08 -$0.75-0.92% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 181.58% 195.71% 197.68% 190.65% 6.01%
Total Depreciation and Amortization 0.07% 3.44% 7.11% 3.97% 6.76%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -6,697.23% -2,957.32% -2,718.05% -2,439.67% 46.16%
Change in Net Operating Assets 89.85% 107.99% 50.73% 96.89% -42.36%
Cash from Operations -8.22% 65.88% -39.46% -22.61% -7.90%
Capital Expenditure 29.66% 5.33% 0.24% -24.53% -23.55%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -2,408.26% -2,408.26% -1,015.34% -408.22% 132.58%
Divestitures -- -- -- -- --
Other Investing Activities -215.04% -164.27% -157.53% -102.42% 57.09%
Cash from Investing 600.41% 887.77% 1,230.78% 1,041.39% 906.09%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 16.94% -11.99% 5.65% 12.12% 12.92%
Repurchase of Common Stock -67.67% -132.80% -31.81% -23.94% 36.14%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -1,057.38% 4.35% -138.46% 60.00% 405.00%
Cash from Financing -95.03% -194.26% -38.26% -25.40% 44.35%
Foreign Exchange rate Adjustments -206.46% -63.52% 129.76% -890.00% 1,348.39%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 167.26% 444.47% 409.00% 1,299.20% 492.92%